Market closed
Kintara Therapeutics Inc/$HURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kintara Therapeutics Inc
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
Ticker
$HURA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
19
ISIN
US8989201038
Website
HURA Metrics
BasicAdvanced
$171M
-
-$0.92
-
-
Price and volume
Market cap
$171M
52-week high
$4.44
52-week low
$1.80
Average daily volume
146K
Financial strength
Current ratio
2.996
Quick ratio
1.301
Total debt to equity
1.67
Interest coverage (TTM)
-5.17%
Management effectiveness
Valuation
Price to book
17.88
Price to tangible book (TTM)
17.88
Price to free cash flow (TTM)
-6.595
Growth
HURA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Kintara Therapeutics Inc stock?
Kintara Therapeutics Inc (HURA) has a market cap of $171M as of May 19, 2025.
What is the P/E ratio for Kintara Therapeutics Inc stock?
The price to earnings (P/E) ratio for Kintara Therapeutics Inc (HURA) stock is 0 as of May 19, 2025.
Does Kintara Therapeutics Inc stock pay dividends?
No, Kintara Therapeutics Inc (HURA) stock does not pay dividends to its shareholders as of May 19, 2025.
When is the next Kintara Therapeutics Inc dividend payment date?
Kintara Therapeutics Inc (HURA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kintara Therapeutics Inc?
Kintara Therapeutics Inc (HURA) does not currently have a Beta indicator.